MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/infdis/jiaa608

Медицинская библиотека · The Journal of infectious diseases · 2021

Antibody Combinations Targeting the Essential Antigens CyRPA, RH5, and MSP-119 Potently Neutralize Plasmodium falciparum Clinical Isolates From India and Africa.

Singh Hina, Mian Syed Yusuf, Pandey Alok K, Krishna Sri, Anand Gaurav, Reddy K Sony, Chaturvedi Neha, Bahl Vanndita, Hans Nidhi, Shukla Man Mohan, Bassat Quique, Mayor Alfredo, Miura Kazutoyo, Bharti Praveen K, Long Carole, Singh Neeru, Chauhan Virander Singh, Gaur Deepak

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

BACKGROUND

Targeting multiple key antigens that mediate distinct Plasmodium falciparum erythrocyte invasion pathways is an attractive approach for the development of blood-stage malaria vaccines. However, the challenge is to identify antigen cocktails that elicit potent strain-transcending parasite-neutralizing antibodies efficacious at low immunoglobulin G concentrations feasible to achieve through vaccination. Previous reports have screened inhibitory antibodies primarily against well adapted laboratory parasite clones. However, validation of the parasite-neutralizing efficacy against clinical isolates with minimal in vitro cultivation is equally significant to better ascertain their prospective in vivo potency.

METHODS

We evaluated the parasite-neutralizing activity of different antibodies individually and in combinations against laboratory adapted clones and clinical isolates. Clinical isolates were collected from Central India and Mozambique, Africa, and characterized for their invasion properties and genetic diversity of invasion ligands.

RESULTS

In our portfolio, we evaluated 25 triple antibody combinations and identified the MSP-Fu+CyRPA+RH5 antibody combination to elicit maximal parasite neutralization against P. falciparum clinical isolates with variable properties that underwent minimal in vitro cultivation.

CONCLUSIONS

The MSP-Fu+CyRPA+RH5 combination exhibited highly robust parasite neutralization against P. falciparum clones and clinical isolates, thus substantiating them as promising candidate antigens and establishing a proof of principle for the development of a combinatorial P. falciparum blood-stage malaria vaccine.

Для цитирования: Singh Hina, Mian Syed Yusuf, Pandey Alok K, Krishna Sri, Anand Gaurav, Reddy K Sony, Chaturvedi Neha, Bahl Vanndita, Hans Nidhi, Shukla Man Mohan, Bassat Quique, Mayor Alfredo, Miura Kazutoyo, Bharti Praveen K, Long Carole, Singh Neeru, Chauhan Virander Singh, Gaur Deepak. Antibody Combinations Targeting the Essential Antigens CyRPA, RH5, and MSP-119 Potently Neutralize Plasmodium falciparum Clinical Isolates From India and Africa.. The Journal of infectious diseases. 2021. DOI: 10.1093/infdis/jiaa608.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.